What were the main outcomes of CME Group's 2025 Annual Meeting of Shareholders?

The primary outcomes included the election of fourteen Equity Directors, the ratification of Ernst & Young LLP as the independent auditor, and the approval of the advisory vote on executive compensation. However, a quorum was not achieved for the election of several Class B Directors, meaning incumbent Class B Directors will continue in their roles as "holdovers" until the 2026 meeting.

Why did some Class B Directors become "holdovers"?

The "holdover" status for certain Class B Directors occurred because the annual meeting did not achieve the required quorum for those specific director elections. Under Delaware law and CME Group's bylaws, these directors will continue to serve until their successors are duly elected at the next annual meeting or until their earlier resignation or removal.

How did shareholders vote on executive compensation?

Shareholders voted in favor of the advisory resolution on the compensation of the Company's named executive officers, indicating general approval of the executive compensation practices.

What is the significance of the broker non-votes?

Broker non-votes, totaling 23,859,420 for both the advisory compensation vote and director elections, represent shares held by brokerage firms on behalf of clients where the broker did not have discretionary authority to vote on the specific proposals and did not receive instructions from the beneficial owner. While these votes are not counted for or against a proposal, their presence can indicate the level of shareholder engagement or the complexities of the voting process for certain types of shareholders.

CME 8-K: Shareholder Matters

Summary

CME Group Inc. (CME) filed an 8-K on May 8, 2025, detailing the results of its 2025 Annual Meeting of Shareholders held on May 8, 2025. The filing primarily reports on shareholder votes for director elections, the ratification of its independent auditor, and an advisory vote on executive compensation. A significant aspect of the meeting was the election of directors, where all fourteen proposed Equity Directors received substantial support and were elected. The appointment of Ernst & Young LLP as the independent auditor for 2025 was also overwhelmingly ratified, and shareholders approved the advisory "say-on-pay" proposal regarding executive compensation. A noteworthy outcome was the failure to achieve a quorum for the election of Class B Directors across several categories (B-1, B-2, and B-3). Consequently, incumbent directors in these categories will continue to serve as "holdovers" until their successors are elected at the 2026 Annual Meeting. This situation highlights a potential governance point for Class B shareholders to consider in future meetings. Overall, the meeting demonstrated strong shareholder alignment on key governance and executive compensation matters, with the exception of specific Class B director elections.

Key Highlights

1Shareholders overwhelmingly elected all fourteen proposed Equity Directors to serve until 2026.
2The appointment of Ernst & Young LLP as the Company's independent public accounting firm for 2025 was ratified with strong shareholder approval.
3Shareholders approved the advisory "say-on-pay" vote concerning the compensation of named executive officers.
4A quorum was not achieved for the election of Class B-1 Directors, resulting in three directors serving as "holdovers" until 2026.
5A quorum was not achieved for the election of Class B-2 Directors, resulting in one director serving as a "holdover" and a vacancy for another position.
6A quorum was not achieved for the election of a Class B-3 Director, resulting in the incumbent director serving as a "holdover" until 2026.
7The meeting saw high participation, with approximately 86.47% of issued and outstanding Class A and Class B common stock represented.

CME GROUP INC. 8-K Report, Shareholder Vote Results (May 9, 2025)

Summary

Key Highlights

Frequently Asked Questions